Jürgen Frisch, M.D., has been appointed chief medical officer of European Operations at Clinipace Worldwide. Dr. Jürgen is responsible for providing leadership and direction to the medical and regulatory service groups. Dr. Jürgen is based in the Zurich office.

Dr. Jürgen has held several senior medical and management positions at multinational pharmaceutical and biotechnology companies, including Eidetica Biopharma (a subsidiary of Biogen Idec), immatics biotechnologies, Intercell, Genetics Institute, HMR Hoechst Marion Roussel, and Behringwerke. Prior to joining Clinipace, Dr. Jürgen served as a medical reviewer at Swissmedic (Medical Health Authority) in Bern, Switzerland.  

“With Jürgen’s expertise as a researcher and drug developer, clients worldwide will receive the very best guidance and advisory services for their drug development programs,” said Kurt Pfister, chief executive officer of European Operations at Clinipace Worldwide.